Director's Dealing • Jun 21, 2024
Director's Dealing
Open in ViewerOpens in native device viewer
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.
| 1. | Details of the person discharging managerial responsibilities/person closely associated | June 21, 2024 | |
|---|---|---|---|
| a) | Name | Novo Holdings A/S | |
| 2. | Reason for the notification | Contact information | |
| a) | Position/status | Novo Holding A/S is closely related to its CEO Kasim Kutay, who is a member of Novonesis' board of directors |
Tobias Bjorklund +45 3077 8682 |
| b) | Initial notification/ Amendment |
Initial notification | [email protected] |
| 3. | auction monitor | Details of the issuer, emission allowance market participant, auction platform, auctioneer or | Anders Enevoldsen +45 5350 1453 [email protected] |
| a) | Name | Novozymes A/S, part of Novonesis Group | |
| b) | LEI | 529900T6WNZXD2R3JW38 | Disa Tuominen +45 6038 5826 |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||
| a) | Description ofthe financial instrument, type of instrument Identification code |
B-Shares DK0060336014 |
|
| b) | Nature of the transaction | Purchase of shares | |
| c) | Price(s) and volume(s) | Price: 441.5135 Volume: 7,623,830 shares |
|
| d) | Aggregated information - Aggregated volume - Price |
Number of shares: 7,623,830 Average price, DKK: 441.5135 Transaction value, DKK: 3,366,023,866 |
|
| e) | Date of transaction | June 20, 2024 | |
| f) | Place of the transaction | Outside a trading window |
Company announcement No. 23
Novozymes A/S, part of Novonesis Group Krogshoejvej 36 2880 Bagsvaerd Denmark
Novonesis is a global leading biosolutions company transforming the way we all produce, consume and live. In more than 30 industries our biosolutions are helping companies meet their business needs and the needs of our planet. Our 10,000 people worldwide work closely with our partners and customers to challenge conventional thinking and transform business with biology.
CVR number: 10 00 71 27 – LEI: 529900T6WNZXD2R3JW38
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.